Biotechnology News

May 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited (TSE:4502) today announced that 101 abstracts featuring the Company’s oncology molecules have been accepted...

May 23, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that the validation period is complete and Health Canada has accepted for review its New Drug Submission (NDS) for the use of ADCETRIS (brentuximab vedotin) in...

May 23, 2012

ALAMEDA, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--XenneX, a Division of LifeMap Sciences, Inc. and BioTime, Inc. (NYSE Amex:BTX), announced today the release of GeneCards®, Version 3.08, on May 20, 2012. The new release is available at...

May 23, 2012

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Therapure Biopharma wins BIOTECanada Gold Leaf Award

May 23, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends found that nephrologists tend to overestimate the percent of dialysis patients being treated with phosphate binders

May 23, 2012

CAMBRIDGE, Mass. & NORWICH, United Kingdom--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Plant Bioscience Limited (PBL), a technology development and intellectual property (IP)...

May 23, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the following investor conferences during the month of June: Goldman Sachs 33rd Annual Global Healthcare Conference on Wednesday, June 6, 2012...

May 23, 2012

TORONTO, Ontario--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the embolization particle segment of the Asia Pacific transcatheter embolization and occlusion (TEO)...

May 23, 2012

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD announced today that its board of directors has named David Simmons chairman and CEO. Mr. Simmons, an experienced pharmaceutical industry executive, joins PPD from Pfizer Inc.

May 23, 2012

BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc. announced today that it has entered into a collaboration and license agreement with Laboratory Corporation of America® Holdings (LabCorp) (NYSE: LH) whereby each party will collaborate in marker...

May 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced the initiation of a Phase 1 study examining the safety and preliminary efficacy of AV-203 along with exploratory biomarkers in patients with advanced solid tumors. AV...

May 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that the Cold Spring Harbor Laboratory (CSHL) has joined the Illumina Genome Network (IGN) to provide researchers with broader access to whole genome sequencing (WGS)...

May 23, 2012

--(BUSINESS WIRE)--Biotechnology Information Organization (BIO): WHAT:   A roundtable discussion featuring Senators, bioscience industry leaders and CEOs, and Congressional staff about the challenges and opportunities faced by bioscience...

May 23, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For NON-US Media Only Today the 1 Mission 1 Million – Getting to the Heart of Stroke initiative announces its plans to support ongoing work in atrial fibrillation (AF) by providing €100,000 in funding....

May 23, 2012

SCOTTSDALE, Ariz. & SAN DIEGO--(BUSINESS WIRE)--Makucell, a biotechnology start-up that manufactures and sells the Renewnt anti-aging skin care line was chosen by the San Diego Venture Group as a "Cool Company" for the 10th Annual Venture...

May 22, 2012

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management today announced that L’Oreal’s Active Cosmetics Division (ACD) has successfully deployed the Mobile Intelligence, cloud-based Customer Relationship Management (CRM) solution to support their...

May 22, 2012

ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO, a full service Contract Research Organization, known for predictable, on-time enrollment and project delivery, announced today that Oscar Podesta has joined PSI as Head of Latin America. He holds a...

May 22, 2012

SAN MATEO, Calif.--(BUSINESS WIRE)--Deltagen, Inc. (Pink Sheets:DGEN), a leading provider of drug discovery tools and services to the biopharmaceutical industry, today reported unaudited consolidated financial results for the three months ended...

May 22, 2012

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) today announced its presentation at Sanford C. Bernstein’s 28th Annual Strategic Decisions Conference on Wednesday, May 30, 2012 at 3:00p.m. EST will be webcast live and will be...

May 22, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), priced an underwritten offering of $600 million aggregate principal amount of 1.350% senior notes due...

May 22, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) held its 2012 Annual Meeting of Stockholders today in San Mateo, California. Impax stockholders elected to a one-year term each of the seven nominees for director named in...

May 22, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apolipoprotein A-IV identified as potential Type 2 diabetes drug target in studies published by Apofore Corporation scientific founder

May 22, 2012

HOUSTON--(BUSINESS WIRE)--PLx Pharma Inc., a specialty pharmaceutical company developing a novel aspirin and lipid complex (PL2200 Aspirin 325 mg), reports that the United States Food and Drug Administration (FDA) has accepted for review a new...

May 22, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--At their meeting today, the Board of Directors of Merck & Co., Inc. declared a quarterly dividend of $0.42 per share on the company’s common stock for the third quarter of 2012. Payment will be made...

May 22, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--Data demonstrates clinical activity of tiotropium, a long-acting bronchodilator, in adolescents with asthma on top of usual care. Comprehensive Phase III UniTinA-asthma™ program ongoing.

May 22, 2012

CLARENCE, N.Y.--(BUSINESS WIRE)--Greatbatch, Inc. today announced it will establish a new global headquarters in Frisco, Texas, as part of the company’s continued approach to advance its medical device strategy. Over the past several years,...

May 22, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Pfizer’s oncology leadership team at an analyst and investor meeting on Sunday, June 3, 2012 at 6:00 p.m. Central...

May 22, 2012

PARIS--(BUSINESS WIRE)--In 2011, France Biotech, the French association of life science companies, in partnership with Ernst & Young, published for the 10th year running the ‘Life Science Panorama’, describing the industry’s main trends for...

May 22, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), launched an underwritten offering of senior notes (the “Notes”). These notes will be fully and...

May 22, 2012

GARFIELD HEIGHTS, Ohio--(BUSINESS WIRE)--AxioMed® Spine Corporation (www.axiomed.com), a spinal orthopedics company focused on the development of products designed to restore spinal...

May 22, 2012

WAKEFIELD, Mass.--(BUSINESS WIRE)--ActiViews, Inc, a company pioneering the development of simple, accurate, and cost-effective surgical navigation solutions, announced today that China’s State Food and Drug Administration (SFDA) has granted...

May 22, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (NASDAQ:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals and pharmaceuticals, today announced a three-year extension of its catalyst and...

May 22, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--McCarter & English LLP is pleased to announce that Thomas A. Stevens, Assistant General Counsel, Global IP Litigation, at AstraZeneca Pharmaceuticals and formerly a senior deputy attorney general in Delaware...

May 22, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics will host a conference call to provide an update following the Company's annual meeting of shareholders.

May 22, 2012

WAYNE, Pa.--(BUSINESS WIRE)--Safeguard Scientifics is hosting its annual shareholders meeting on Thursday, May 24th at 8am EDT at the Radnor Hotel in St. Davids, PA. The event will be webcast at...

May 22, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today announced that its subsidiary LifeMap Sciences, Inc. has entered into a license agreement with Yeda Research and Development Company Ltd, the technology transfer arm of the...

May 22, 2012

MONTREAL--(BUSINESS WIRE)--Sunshine Biopharma Inc. (OTCBB: SBFM) a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer, today announced that it...

May 22, 2012

SAN DIEGO--(BUSINESS WIRE)--Platelet Reactivity Testing Can Benefit Patients, Providers and Payers

May 22, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Each year, The New Health Report examines stakeholder opinions and perceptions on a pressing industry topic -- this year the focus is risk.

May 22, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, today announced the appointment of Alfred Sandrock, M.D., Ph.D., to the company’s board of...

May 22, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Alvine Presents Phase 2A Trial Data at 2012 DDW Meeting.

May 22, 2012

NEW YORK, LONDON & HAMILTON, Bermuda--(BUSINESS WIRE)--Celtic Pharma Announces Successful Completion of Phase I/II study of Xerecept® in Pediatric Patients with Cerebral Tumors

May 22, 2012

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics' two core businesses--Medical Device Coatings and In Vitro Diagnostics--are now fully represented on its new website.

May 22, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--Wellstat Therapeutics Corporation announced today that it has granted Named Patient supply rights and an option to obtain marketing rights in the European Union for the company’s investigational drug

May 22, 2012

EXTON, Pa.--(BUSINESS WIRE)--Multiple myeloma is perceived by surveyed hematologist-oncologists to have the third greatest need for new/ improved therapies across seven profiled hematology-oncology indications.

May 22, 2012

CINCINNATI, Ohio--(BUSINESS WIRE)--Camargo Pharmaceutical Services has appointed K. Gary Barnette as Vice President of drug development, a key appointment as the company continues to expand.

May 22, 2012

NEW YORK--(BUSINESS WIRE)--New York Genome Center (NYGC) today announced the formal commencement of their collaborative relationship with Illumina, initiated in November 2011, when Illumina was selected as the Center’s lead sequencing technology...

May 22, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year ended April 27, 2012. The company reported worldwide fourth quarter revenue of $4.297 billion, compared to the $4....